Complete Metabolic Response in FDG-PET-CT Scan before Discontinuation of Immune Checkpoint Inhibitors Correlates with Long Progression-Free Survival

SIMPLE SUMMARY: Immunotherapy is the standard of care in patients harboring metastasized melanoma. However, once further tumor growth is stopped it remains unclear when immunotherapy can be safely ceased. This clinical question is increasingly raised especially in patients with a strong desire to di...

Descripción completa

Detalles Bibliográficos
Autores principales: Schank, Timo E., Forschner, Andrea, Sachse, Michael Max, Dimitrakopoulou-Strauss, Antonia, Sachpekidis, Christos, Stenzinger, Albrecht, Volckmar, Anna-Lena, Enk, Alexander, Hassel, Jessica C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198795/
https://www.ncbi.nlm.nih.gov/pubmed/34073477
http://dx.doi.org/10.3390/cancers13112616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198795/
https://www.ncbi.nlm.nih.gov/pubmed/34073477
http://dx.doi.org/10.3390/cancers13112616

Ejemplares similares